US 7332484
2,4-pyrimidinediamine compounds and their uses
granted A61KA61K31/505A61K31/506
Quick answer
US patent 7332484 (2,4-pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/505, A61K31/506, A61K31/519, A61K31/5377